Literature DB >> 28252962

Merocyclophanes C and D from the Cultured Freshwater Cyanobacterium Nostoc sp. (UIC 10110).

Daniel S May1, Wei-Lun Chen1, Daniel D Lantvit1, Xiaoli Zhang2, Aleksej Krunic1, Joanna E Burdette1, Alessandra Eustaquio1, Jimmy Orjala1.   

Abstract

Merocyclophanes C and D (1 and 2) were isolated from the cell extract of the cultured cyanobacterium UIC 10110. The structures were determined by one-dimensional nuclear magnetic resonance (NMR) and high-resolution electrospray ionization mass spectrometry and confirmed by 2D NMR techniques. The absolute configurations were determined using electronic circular dichroism spectroscopy. Merocyclophanes C and D represent the first known analogues of the merocyclophane core structure, a recently discovered scaffold of [7,7] paracyclophanes characterized by an α-branched methyl at C-1/C-14; 1 and 2 showed antiproliferative activity against the MDA-MB-435 cell line with IC50 values of 1.6 and 0.9 μM, respectively. Partial 16S analysis determined UIC 10110 to be a Nostoc sp., and it was found to clade with UIC 10062 Nostoc sp., the only other strain known to produce merocyclophanes. The genome of UIC 10110 was sequenced, and a biosynthetic gene cluster was identified that is proposed to encode type I and type III polyketide synthases that are potentially responsible for production of the merocyclophanes; however, further experiments will be required to verify the true function of the gene cluster. The gene cluster provides a genetic basis for the observed structural differences of the [7,7] paracyclophane core structures.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28252962      PMCID: PMC5898374          DOI: 10.1021/acs.jnatprod.6b01175

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  21 in total

1.  Cylindrofridins A-C, Linear Cylindrocyclophane-Related Alkylresorcinols from the Cyanobacterium Cylindrospermum stagnale.

Authors:  Michael Preisitsch; Timo H J Niedermeyer; Stefan E Heiden; Inga Neidhardt; Jana Kumpfmüller; Martina Wurster; Kirsten Harmrolfs; Christoph Wiesner; Heike Enke; Rolf Müller; Sabine Mundt
Journal:  J Nat Prod       Date:  2015-12-18       Impact factor: 4.050

Review 2.  Cyanobacteria: an emerging source for drug discovery.

Authors:  Rahul Kunwar Singh; Shree Prakash Tiwari; Ashwani K Rai; Tribhuban M Mohapatra
Journal:  J Antibiot (Tokyo)       Date:  2011-04-06       Impact factor: 2.649

3.  U.S. Food and Drug Administration approval summary: brentuximab vedotin for the treatment of relapsed Hodgkin lymphoma or relapsed systemic anaplastic large-cell lymphoma.

Authors:  R Angelo de Claro; Karen McGinn; Virginia Kwitkowski; Julie Bullock; Aakanksha Khandelwal; Bahru Habtemariam; Yanli Ouyang; Haleh Saber; Kyung Lee; Kallappa Koti; Mark Rothmann; Marjorie Shapiro; Francisco Borrego; Kathleen Clouse; Xiao Hong Chen; Janice Brown; Lara Akinsanya; Robert Kane; Edvardas Kaminskas; Ann Farrell; Richard Pazdur
Journal:  Clin Cancer Res       Date:  2012-09-07       Impact factor: 12.531

4.  Phase II study of dolastatin-10 in patients with hormone-refractory metastatic prostate adenocarcinoma.

Authors:  U Vaishampayan; M Glode; W Du; A Kraft; G Hudes; J Wright; M Hussain
Journal:  Clin Cancer Res       Date:  2000-11       Impact factor: 12.531

5.  Anti-MRSA-acting carbamidocyclophanes H-L from the Vietnamese cyanobacterium Nostoc sp. CAVN2.

Authors:  Michael Preisitsch; Kirsten Harmrolfs; Hang T L Pham; Stefan E Heiden; Anna Füssel; Christoph Wiesner; Alexander Pretsch; Monika Swiatecka-Hagenbruch; Timo H J Niedermeyer; Rolf Müller; Sabine Mundt
Journal:  J Antibiot (Tokyo)       Date:  2014-09-03       Impact factor: 2.649

6.  Cylindrocyclophanes with proteasome inhibitory activity from the Cyanobacterium Nostoc sp.

Authors:  George E Chlipala; Megan Sturdy; Aleksej Krunic; Daniel D Lantvit; Qi Shen; Kyle Porter; Steven M Swanson; Jimmy Orjala
Journal:  J Nat Prod       Date:  2010-09-24       Impact factor: 4.050

7.  Carbamidocyclophanes F and G with Anti-Mycobacterium tuberculosis Activity from the Cultured Freshwater Cyanobacterium Nostoc sp.

Authors:  Shangwen Luo; Hahk-Soo Kang; Aleksej Krunic; George E Chlipala; Geping Cai; Wei-Lun Chen; Scott G Franzblau; Steven M Swanson; Jimmy Orjala
Journal:  Tetrahedron Lett       Date:  2014-01-15       Impact factor: 2.415

8.  Emerging Pharmacotherapy for Relapsed or Refractory Hodgkin's Lymphoma: Focus on Brentuximab Vedotin.

Authors:  Michelle Furtado; Simon Rule
Journal:  Clin Med Insights Oncol       Date:  2012-01-04

9.  Effects of Halide Ions on the Carbamidocyclophane Biosynthesis in Nostoc sp. CAVN2.

Authors:  Michael Preisitsch; Stefan E Heiden; Monika Beerbaum; Timo H J Niedermeyer; Marie Schneefeld; Jennifer Herrmann; Jana Kumpfmüller; Andrea Thürmer; Inga Neidhardt; Christoph Wiesner; Rolf Daniel; Rolf Müller; Franz-Christoph Bange; Peter Schmieder; Thomas Schweder; Sabine Mundt
Journal:  Mar Drugs       Date:  2016-01-20       Impact factor: 5.118

10.  Assembly line termination in cylindrocyclophane biosynthesis: discovery of an editing type II thioesterase domain in a type I polyketide synthase.

Authors:  H Nakamura; J X Wang; E P Balskus
Journal:  Chem Sci       Date:  2015-04-14       Impact factor: 9.825

View more
  12 in total

1.  Discovery of Anticancer Agents of Diverse Natural Origin.

Authors:  Leslie N Aldrich; Joanna E Burdette; Esperanza Carcache de Blanco; Christopher C Coss; Alessandra S Eustaquio; James R Fuchs; A Douglas Kinghorn; Amanda MacFarlane; Brittney K Mize; Nicholas H Oberlies; Jimmy Orjala; Cedric J Pearce; Mitch A Phelps; Liva Harinantenaina Rakotondraibe; Yulin Ren; Djaja Doel Soejarto; Brent R Stockwell; Jack C Yalowich; Xiaoli Zhang
Journal:  J Nat Prod       Date:  2022-02-25       Impact factor: 4.803

2.  Cyanobacteria Nostoc Punctiforme from Abyssal Benthos of Lake Baikal: Unique Ecology and Metabolic Potential.

Authors:  Irina Tikhonova; Anton Kuzmin; Diana Deeva; Ekaterina Sorokovikova; Sergey Potapov; Anna Lomakina; Olga Belykh
Journal:  Indian J Microbiol       Date:  2017-09-13       Impact factor: 2.461

3.  Ribocyclophanes A-E, Glycosylated Cyclophanes with Antiproliferative Activity from Two Cultured Terrestrial Cyanobacteria.

Authors:  Daniel S May; Hahk-Soo Kang; Bernard D Santarsiero; Aleksej Krunic; Qi Shen; Joanna E Burdette; Steven M Swanson; Jimmy Orjala
Journal:  J Nat Prod       Date:  2018-01-30       Impact factor: 4.050

4.  A new strategy for aromatic ring alkylation in cylindrocyclophane biosynthesis.

Authors:  Hitomi Nakamura; Erica E Schultz; Emily P Balskus
Journal:  Nat Chem Biol       Date:  2017-06-26       Impact factor: 15.040

5.  The impact of culture conditions on growth and metabolomic profiles of freshwater cyanobacteria.

Authors:  Camila M Crnkovic; Daniel S May; Jimmy Orjala
Journal:  J Appl Phycol       Date:  2017-09-14       Impact factor: 3.215

6.  15N Stable Isotope Labeling and Comparative Metabolomics Facilitates Genome Mining in Cultured Cyanobacteria.

Authors:  Daniel S May; Camila M Crnkovic; Aleksej Krunic; Tyler A Wilson; James R Fuchs; Jimmy E Orjala
Journal:  ACS Chem Biol       Date:  2020-03-04       Impact factor: 5.100

7.  Discovery of Unusual Cyanobacterial Tryptophan-Containing Anabaenopeptins by MS/MS-Based Molecular Networking.

Authors:  Subhasish Saha; Germana Esposito; Petra Urajová; Jan Mareš; Daniela Ewe; Alessia Caso; Markéta Macho; Kateřina Delawská; Andreja Kust; Pavel Hrouzek; Josef Juráň; Valeria Costantino; Kumar Saurav
Journal:  Molecules       Date:  2020-08-20       Impact factor: 4.411

8.  Phormidepistatin from the Cyanobacterium UIC 10484: Assessing the Phylogenetic Distribution of the Statine Pharmacophore.

Authors:  Peter Sullivan; Aleksej Krunic; Lydia J Davis; Hwan Seung Kim; Joanna E Burdette; Jimmy Orjala
Journal:  J Nat Prod       Date:  2021-07-27       Impact factor: 4.803

Review 9.  Chemistry, bioactivity and biosynthesis of cyanobacterial alkylresorcinols.

Authors:  Teresa P Martins; Caroline Rouger; Nathaniel R Glasser; Sara Freitas; Nelly B de Fraissinette; Emily P Balskus; Deniz Tasdemir; Pedro N Leão
Journal:  Nat Prod Rep       Date:  2019-10-16       Impact factor: 13.423

10.  Divergent Synthesis of Novel Cylindrocyclophanes that Inhibit Methicillin-Resistant Staphylococcus aureus (MRSA).

Authors:  Julien J Freudenreich; Sean Bartlett; Naomi S Robertson; Sarah L Kidd; Suzie Forrest; Hannah F Sore; Warren R J D Galloway; Martin Welch; David R Spring
Journal:  ChemMedChem       Date:  2020-06-12       Impact factor: 3.540

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.